QIAGEN Sciences Inc
QIAGEN Sciences Inc
Categories
Medical Device/ Diagnostic
About
Qiagen offers testing solutions for infectious diseases – most notably TB, HIV, hepatitis, herpes and cytomegalovirus (CMV) – as well as oncology, and immune response modulation. In March 2020, Qiagen’s QIAstat-Dx Respiratory SARS-CoV-2 Panel, which is an RT-PCR test for detecting and differentiating nucleic acids from multiple respiratory viral and bacterial organisms, received an FDA EUA that allowed it to be used for diagnosing Covid-19.
Industry News & Announcements
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – biotechnology and diagnostic companies, medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.